Everyone's Talking About These 2 Biotech IPO Stocks

[cafead]

via

• Biotech businesses tend to be volatile after their initial public offerings.
• Kyverna Therapeutics raised more than twice what was initially expected.
• CG Oncology has plenty of cash, and a mature therapy candidate.

article source